Long-term health effects among testicular cancer survivors
Purpose Testicular cancer is diagnosed at a young age and survival rates are high; thus, the long-term effects of cancer treatment need to be assessed. Our objectives are to estimate the incidence rates and determinants of late effects in testicular cancer survivors. Methods We conducted a populatio...
Gespeichert in:
| Veröffentlicht in: | Journal of cancer survivorship 2016-12, Vol.10 (6), p.1051-1057 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1057 |
|---|---|
| container_issue | 6 |
| container_start_page | 1051 |
| container_title | Journal of cancer survivorship |
| container_volume | 10 |
| creator | Hashibe, Mia Abdelaziz, Sarah Al-Temimi, Mohammed Fraser, Alison Boucher, Kenneth M. Smith, Ken Lee, Yuan-chin Amy Rowe, Kerry Rowley, Braden Daurelle, Micky Holton, Avery E. VanDerslice, James Richiardi, Lorenzo Bishoff, Jay Lowrance, Will Stroup, Antoinette |
| description | Purpose
Testicular cancer is diagnosed at a young age and survival rates are high; thus, the long-term effects of cancer treatment need to be assessed. Our objectives are to estimate the incidence rates and determinants of late effects in testicular cancer survivors.
Methods
We conducted a population-based cohort study of testicular cancer survivors, diagnosed 1991–2007, followed up for a median of 10 years. We identified 785 testicular cancer patients who survived ≥5 years and 3323 men free of cancer for the comparison group. Multivariate Cox regression analysis was used to compare the hazard ratio between the cases and the comparison group and for internal analysis among case patients.
Results
Testicular cancer survivors experienced a 24 % increase in risk of long-term health effects >5 years after diagnosis. The overall incidence rate of late effects among testicular cancer survivors was 66.3 per 1000 person years. Higher risks were observed among testicular cancer survivors for hypercholesterolemia, infertility, and orchitis. Chemotherapy and retroperitoneal lymph node dissection appeared to increase the risk of late effects. Being obese prior to cancer diagnosis appeared to be the strongest factor associated with late effects.
Conclusions
Testicular cancer survivors were more likely to develop chronic health conditions when compared to cancer-free men.
Implications for Cancer Survivors
While the late effects risk was increased among testicular cancer survivors, the incidence rates of late effects after cancer diagnosis was fairly low. |
| doi_str_mv | 10.1007/s11764-016-0548-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5096990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4237368421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-e2759e54ead16b087f12877c27e8f12b72a4901048739d6731cf76a22b2a03df3</originalsourceid><addsrcrecordid>eNqNkU1LAzEQhoMo1q8f4EUWvHhZzcxuko0HQYpfUPCi55Cms-2W_dBkt-C_N1ItKgieMjDPvJN3XsaOgZ8D5-oiACiZpxxkykVepLDF9kBnmCJKtb2phR6x_RCWnAvUgLtshAqk1hr32OWka-dpT75JFmTrfpFQWZLrQ2Kb2El6Cn3lhtr6xNnWkU_C4FfVqvPhkO2Utg509PkesOfbm6fxfTp5vHsYX09SJ3jWp4RKaBI52RnIKS9UCVgo5VBREcupQptrDjwvVKZnUmXgSiUt4hQtz2ZldsCu1rovw7ShmaO297Y2L75qrH8zna3Mz05bLcy8WxnBdXTJo8DZp4DvXodoyDRVcFTXtqVuCAaKXOYA8Yz_QFHKIo-OInr6C112g2_jJSKVCSk5ChEpWFPOdyF4Kjf_Bm4-QjTrEE3cbj5CNBBnTr4b3kx8pRYBXAMhtto5-W-r_1R9BxPdpjw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835660255</pqid></control><display><type>article</type><title>Long-term health effects among testicular cancer survivors</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Hashibe, Mia ; Abdelaziz, Sarah ; Al-Temimi, Mohammed ; Fraser, Alison ; Boucher, Kenneth M. ; Smith, Ken ; Lee, Yuan-chin Amy ; Rowe, Kerry ; Rowley, Braden ; Daurelle, Micky ; Holton, Avery E. ; VanDerslice, James ; Richiardi, Lorenzo ; Bishoff, Jay ; Lowrance, Will ; Stroup, Antoinette</creator><creatorcontrib>Hashibe, Mia ; Abdelaziz, Sarah ; Al-Temimi, Mohammed ; Fraser, Alison ; Boucher, Kenneth M. ; Smith, Ken ; Lee, Yuan-chin Amy ; Rowe, Kerry ; Rowley, Braden ; Daurelle, Micky ; Holton, Avery E. ; VanDerslice, James ; Richiardi, Lorenzo ; Bishoff, Jay ; Lowrance, Will ; Stroup, Antoinette</creatorcontrib><description>Purpose
Testicular cancer is diagnosed at a young age and survival rates are high; thus, the long-term effects of cancer treatment need to be assessed. Our objectives are to estimate the incidence rates and determinants of late effects in testicular cancer survivors.
Methods
We conducted a population-based cohort study of testicular cancer survivors, diagnosed 1991–2007, followed up for a median of 10 years. We identified 785 testicular cancer patients who survived ≥5 years and 3323 men free of cancer for the comparison group. Multivariate Cox regression analysis was used to compare the hazard ratio between the cases and the comparison group and for internal analysis among case patients.
Results
Testicular cancer survivors experienced a 24 % increase in risk of long-term health effects >5 years after diagnosis. The overall incidence rate of late effects among testicular cancer survivors was 66.3 per 1000 person years. Higher risks were observed among testicular cancer survivors for hypercholesterolemia, infertility, and orchitis. Chemotherapy and retroperitoneal lymph node dissection appeared to increase the risk of late effects. Being obese prior to cancer diagnosis appeared to be the strongest factor associated with late effects.
Conclusions
Testicular cancer survivors were more likely to develop chronic health conditions when compared to cancer-free men.
Implications for Cancer Survivors
While the late effects risk was increased among testicular cancer survivors, the incidence rates of late effects after cancer diagnosis was fairly low.</description><identifier>ISSN: 1932-2259</identifier><identifier>EISSN: 1932-2267</identifier><identifier>DOI: 10.1007/s11764-016-0548-1</identifier><identifier>PMID: 27169992</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adolescent ; Adult ; Cardiovascular disease ; Cohort Studies ; Epidemiology ; Health Informatics ; Health Promotion and Disease Prevention ; Humans ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Obesity ; Oncology ; Primary Care Medicine ; Public Health ; Quality of Life Research ; Risk ; Survival Rate ; Survivor ; Survivors ; Testicular cancer ; Testicular Neoplasms - mortality ; Young Adult</subject><ispartof>Journal of cancer survivorship, 2016-12, Vol.10 (6), p.1051-1057</ispartof><rights>Springer Science+Business Media New York 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-e2759e54ead16b087f12877c27e8f12b72a4901048739d6731cf76a22b2a03df3</citedby><cites>FETCH-LOGICAL-c503t-e2759e54ead16b087f12877c27e8f12b72a4901048739d6731cf76a22b2a03df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11764-016-0548-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11764-016-0548-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27169992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashibe, Mia</creatorcontrib><creatorcontrib>Abdelaziz, Sarah</creatorcontrib><creatorcontrib>Al-Temimi, Mohammed</creatorcontrib><creatorcontrib>Fraser, Alison</creatorcontrib><creatorcontrib>Boucher, Kenneth M.</creatorcontrib><creatorcontrib>Smith, Ken</creatorcontrib><creatorcontrib>Lee, Yuan-chin Amy</creatorcontrib><creatorcontrib>Rowe, Kerry</creatorcontrib><creatorcontrib>Rowley, Braden</creatorcontrib><creatorcontrib>Daurelle, Micky</creatorcontrib><creatorcontrib>Holton, Avery E.</creatorcontrib><creatorcontrib>VanDerslice, James</creatorcontrib><creatorcontrib>Richiardi, Lorenzo</creatorcontrib><creatorcontrib>Bishoff, Jay</creatorcontrib><creatorcontrib>Lowrance, Will</creatorcontrib><creatorcontrib>Stroup, Antoinette</creatorcontrib><title>Long-term health effects among testicular cancer survivors</title><title>Journal of cancer survivorship</title><addtitle>J Cancer Surviv</addtitle><addtitle>J Cancer Surviv</addtitle><description>Purpose
Testicular cancer is diagnosed at a young age and survival rates are high; thus, the long-term effects of cancer treatment need to be assessed. Our objectives are to estimate the incidence rates and determinants of late effects in testicular cancer survivors.
Methods
We conducted a population-based cohort study of testicular cancer survivors, diagnosed 1991–2007, followed up for a median of 10 years. We identified 785 testicular cancer patients who survived ≥5 years and 3323 men free of cancer for the comparison group. Multivariate Cox regression analysis was used to compare the hazard ratio between the cases and the comparison group and for internal analysis among case patients.
Results
Testicular cancer survivors experienced a 24 % increase in risk of long-term health effects >5 years after diagnosis. The overall incidence rate of late effects among testicular cancer survivors was 66.3 per 1000 person years. Higher risks were observed among testicular cancer survivors for hypercholesterolemia, infertility, and orchitis. Chemotherapy and retroperitoneal lymph node dissection appeared to increase the risk of late effects. Being obese prior to cancer diagnosis appeared to be the strongest factor associated with late effects.
Conclusions
Testicular cancer survivors were more likely to develop chronic health conditions when compared to cancer-free men.
Implications for Cancer Survivors
While the late effects risk was increased among testicular cancer survivors, the incidence rates of late effects after cancer diagnosis was fairly low.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Cardiovascular disease</subject><subject>Cohort Studies</subject><subject>Epidemiology</subject><subject>Health Informatics</subject><subject>Health Promotion and Disease Prevention</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Oncology</subject><subject>Primary Care Medicine</subject><subject>Public Health</subject><subject>Quality of Life Research</subject><subject>Risk</subject><subject>Survival Rate</subject><subject>Survivor</subject><subject>Survivors</subject><subject>Testicular cancer</subject><subject>Testicular Neoplasms - mortality</subject><subject>Young Adult</subject><issn>1932-2259</issn><issn>1932-2267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkU1LAzEQhoMo1q8f4EUWvHhZzcxuko0HQYpfUPCi55Cms-2W_dBkt-C_N1ItKgieMjDPvJN3XsaOgZ8D5-oiACiZpxxkykVepLDF9kBnmCJKtb2phR6x_RCWnAvUgLtshAqk1hr32OWka-dpT75JFmTrfpFQWZLrQ2Kb2El6Cn3lhtr6xNnWkU_C4FfVqvPhkO2Utg509PkesOfbm6fxfTp5vHsYX09SJ3jWp4RKaBI52RnIKS9UCVgo5VBREcupQptrDjwvVKZnUmXgSiUt4hQtz2ZldsCu1rovw7ShmaO297Y2L75qrH8zna3Mz05bLcy8WxnBdXTJo8DZp4DvXodoyDRVcFTXtqVuCAaKXOYA8Yz_QFHKIo-OInr6C112g2_jJSKVCSk5ChEpWFPOdyF4Kjf_Bm4-QjTrEE3cbj5CNBBnTr4b3kx8pRYBXAMhtto5-W-r_1R9BxPdpjw</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Hashibe, Mia</creator><creator>Abdelaziz, Sarah</creator><creator>Al-Temimi, Mohammed</creator><creator>Fraser, Alison</creator><creator>Boucher, Kenneth M.</creator><creator>Smith, Ken</creator><creator>Lee, Yuan-chin Amy</creator><creator>Rowe, Kerry</creator><creator>Rowley, Braden</creator><creator>Daurelle, Micky</creator><creator>Holton, Avery E.</creator><creator>VanDerslice, James</creator><creator>Richiardi, Lorenzo</creator><creator>Bishoff, Jay</creator><creator>Lowrance, Will</creator><creator>Stroup, Antoinette</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20161201</creationdate><title>Long-term health effects among testicular cancer survivors</title><author>Hashibe, Mia ; Abdelaziz, Sarah ; Al-Temimi, Mohammed ; Fraser, Alison ; Boucher, Kenneth M. ; Smith, Ken ; Lee, Yuan-chin Amy ; Rowe, Kerry ; Rowley, Braden ; Daurelle, Micky ; Holton, Avery E. ; VanDerslice, James ; Richiardi, Lorenzo ; Bishoff, Jay ; Lowrance, Will ; Stroup, Antoinette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-e2759e54ead16b087f12877c27e8f12b72a4901048739d6731cf76a22b2a03df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Cardiovascular disease</topic><topic>Cohort Studies</topic><topic>Epidemiology</topic><topic>Health Informatics</topic><topic>Health Promotion and Disease Prevention</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Oncology</topic><topic>Primary Care Medicine</topic><topic>Public Health</topic><topic>Quality of Life Research</topic><topic>Risk</topic><topic>Survival Rate</topic><topic>Survivor</topic><topic>Survivors</topic><topic>Testicular cancer</topic><topic>Testicular Neoplasms - mortality</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashibe, Mia</creatorcontrib><creatorcontrib>Abdelaziz, Sarah</creatorcontrib><creatorcontrib>Al-Temimi, Mohammed</creatorcontrib><creatorcontrib>Fraser, Alison</creatorcontrib><creatorcontrib>Boucher, Kenneth M.</creatorcontrib><creatorcontrib>Smith, Ken</creatorcontrib><creatorcontrib>Lee, Yuan-chin Amy</creatorcontrib><creatorcontrib>Rowe, Kerry</creatorcontrib><creatorcontrib>Rowley, Braden</creatorcontrib><creatorcontrib>Daurelle, Micky</creatorcontrib><creatorcontrib>Holton, Avery E.</creatorcontrib><creatorcontrib>VanDerslice, James</creatorcontrib><creatorcontrib>Richiardi, Lorenzo</creatorcontrib><creatorcontrib>Bishoff, Jay</creatorcontrib><creatorcontrib>Lowrance, Will</creatorcontrib><creatorcontrib>Stroup, Antoinette</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cancer survivorship</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashibe, Mia</au><au>Abdelaziz, Sarah</au><au>Al-Temimi, Mohammed</au><au>Fraser, Alison</au><au>Boucher, Kenneth M.</au><au>Smith, Ken</au><au>Lee, Yuan-chin Amy</au><au>Rowe, Kerry</au><au>Rowley, Braden</au><au>Daurelle, Micky</au><au>Holton, Avery E.</au><au>VanDerslice, James</au><au>Richiardi, Lorenzo</au><au>Bishoff, Jay</au><au>Lowrance, Will</au><au>Stroup, Antoinette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term health effects among testicular cancer survivors</atitle><jtitle>Journal of cancer survivorship</jtitle><stitle>J Cancer Surviv</stitle><addtitle>J Cancer Surviv</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>10</volume><issue>6</issue><spage>1051</spage><epage>1057</epage><pages>1051-1057</pages><issn>1932-2259</issn><eissn>1932-2267</eissn><abstract>Purpose
Testicular cancer is diagnosed at a young age and survival rates are high; thus, the long-term effects of cancer treatment need to be assessed. Our objectives are to estimate the incidence rates and determinants of late effects in testicular cancer survivors.
Methods
We conducted a population-based cohort study of testicular cancer survivors, diagnosed 1991–2007, followed up for a median of 10 years. We identified 785 testicular cancer patients who survived ≥5 years and 3323 men free of cancer for the comparison group. Multivariate Cox regression analysis was used to compare the hazard ratio between the cases and the comparison group and for internal analysis among case patients.
Results
Testicular cancer survivors experienced a 24 % increase in risk of long-term health effects >5 years after diagnosis. The overall incidence rate of late effects among testicular cancer survivors was 66.3 per 1000 person years. Higher risks were observed among testicular cancer survivors for hypercholesterolemia, infertility, and orchitis. Chemotherapy and retroperitoneal lymph node dissection appeared to increase the risk of late effects. Being obese prior to cancer diagnosis appeared to be the strongest factor associated with late effects.
Conclusions
Testicular cancer survivors were more likely to develop chronic health conditions when compared to cancer-free men.
Implications for Cancer Survivors
While the late effects risk was increased among testicular cancer survivors, the incidence rates of late effects after cancer diagnosis was fairly low.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>27169992</pmid><doi>10.1007/s11764-016-0548-1</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-2259 |
| ispartof | Journal of cancer survivorship, 2016-12, Vol.10 (6), p.1051-1057 |
| issn | 1932-2259 1932-2267 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5096990 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Adolescent Adult Cardiovascular disease Cohort Studies Epidemiology Health Informatics Health Promotion and Disease Prevention Humans Male Medicine Medicine & Public Health Middle Aged Obesity Oncology Primary Care Medicine Public Health Quality of Life Research Risk Survival Rate Survivor Survivors Testicular cancer Testicular Neoplasms - mortality Young Adult |
| title | Long-term health effects among testicular cancer survivors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A52%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20health%20effects%20among%20testicular%20cancer%20survivors&rft.jtitle=Journal%20of%20cancer%20survivorship&rft.au=Hashibe,%20Mia&rft.date=2016-12-01&rft.volume=10&rft.issue=6&rft.spage=1051&rft.epage=1057&rft.pages=1051-1057&rft.issn=1932-2259&rft.eissn=1932-2267&rft_id=info:doi/10.1007/s11764-016-0548-1&rft_dat=%3Cproquest_pubme%3E4237368421%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835660255&rft_id=info:pmid/27169992&rfr_iscdi=true |